von Hippel-Lindau disease

00:00 / 00:00

Videos

Notes

von Hippel-Lindau disease

Genetics

Genetic disorders

Achondroplasia

Alagille syndrome (NORD)

Familial adenomatous polyposis

Familial hypercholesterolemia

Hereditary spherocytosis

Huntington disease

Li-Fraumeni syndrome

Marfan syndrome

Multiple endocrine neoplasia

Myotonic dystrophy

Neurofibromatosis

Polycystic kidney disease

Treacher Collins syndrome

Tuberous sclerosis

von Hippel-Lindau disease

Albinism

Alpha-thalassemia

Beta-thalassemia

Cystic fibrosis

Friedreich ataxia

Gaucher disease (NORD)

Glycogen storage disease type I

Glycogen storage disease type II (NORD)

Glycogen storage disease type III

Glycogen storage disease type IV

Glycogen storage disease type V

Hemochromatosis

Krabbe disease

Leukodystrophy

Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)

Niemann-Pick disease type C

Niemann-Pick disease types A and B (NORD)

Phenylketonuria (NORD)

Polycystic kidney disease

Primary ciliary dyskinesia

Sickle cell disease (NORD)

Tay-Sachs disease (NORD)

Wilson disease

Cri du chat syndrome

Williams syndrome

Angelman syndrome

Prader-Willi syndrome

Beckwith-Wiedemann syndrome

Mitochondrial myopathy

Klinefelter syndrome

Turner syndrome

Fragile X syndrome

Friedreich ataxia

Huntington disease

Myotonic dystrophy

Down syndrome (Trisomy 21)

Edwards syndrome (Trisomy 18)

Patau syndrome (Trisomy 13)

Alport syndrome

Fragile X syndrome

Fabry disease (NORD)

Glucose-6-phosphate dehydrogenase (G6PD) deficiency

Hemophilia

Lesch-Nyhan syndrome

Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)

Muscular dystrophy

Ornithine transcarbamylase deficiency

Wiskott-Aldrich syndrome

X-linked agammaglobulinemia

Autosomal trisomies: Pathology review

Miscellaneous genetic disorders: Pathology review

Muscular dystrophies and mitochondrial myopathies: Pathology review

Assessments

von Hippel-Lindau disease

Flashcards

0 / 13 complete

USMLE® Step 1 questions

0 / 2 complete

High Yield Notes

13 pages

Flashcards

von Hippel-Lindau disease

of complete

Questions

USMLE® Step 1 style questions USMLE

of complete

A 29-year-old man comes to the clinic due to headaches and feeling unstable. Over the past 6 months, the patient gradually has been falling more frequently. He has also been experiencing constant headaches which are worse in the morning. He denies any trauma and does not use alcohol illicit drugs. Medical history is notable for pheochromocytoma, treated with surgery 6 months ago. Vitals are within normal limits. On physical examination, he has difficulty ambulating or standing with feet close together. An MRI is obtained and shown below:  
 

Reproduced from: Wikimedia Commons    
Histopathological analysis of this patient's lesion would most likely show which of the following?  

External References

First Aid

2022

2021

2020

2019

2018

2017

2016

Angiomatosis

von Hippel-Lindau disease p. 543, 719

Autosomal dominant disease

Von Hippel-Lindau disease p. 543

Hemangioblastomas p. 543

von Hippel-Lindau disease p. 543, 719

Pheochromocytomas p. 345

von Hippel-Lindau disease p. 543

Renal cell carcinomas p. 623

von Hippel-Lindau disease p. 543, 719

Retina

von Hippel-Lindau disease p. 543

Von Hippel-Lindau disease p. 543

chromosome association p. 62

presentation p. 719

renal cell carcinoma and p. 623

tumor suppressor genes and p. 222

Transcript

Von-Hippel Lindau or VHL is a genetic disease that affects people of all ethnicities and is characterized by tumor development in the CNS, kidneys, adrenal glands and pancreas.

Okay, the VHL gene is a tumor suppressor gene on the short arm of chromosome 3.

It codes for proteins that degrade hypoxia-inducible transcription factor, or HIF. HIF upregulates genes that code for platelet-derived and vascular endothelial growth factors, both of which promote new blood vessel formation and cell growth.

In VHL disease, this tumor suppressor gene is mutated which increases HIF, PDGF, VEGF, and ultimately the risk of tumor formation.

VHL disease is about as common as Huntington Disease, occurring in 1 in 36,000 people.

It is inherited in an autosomal dominant pattern, meaning that a VHL patient has a 50% chance of passing it on to each kid they have.

20% of VHL patients have a de novo or new mutation, meaning they are the first VHL patient in their family.

Alright, the most common tumor type in VHL is hemangioblastoma, a benign blood vessel tumor occurring in about 60% of VHL patients.

In the central nervous system, these can occur in the retina, brain, and spinal cord.

In the eyes, it can cause blindness by detaching the retina.

In the brain and spinal cord, a tumor or the accompanying cyst causes problems when it pushes against surrounding tissue.

For example, if the tumor is in the cerebellum, it can cause ataxia, or the loss of balance.

If it blocks the flow of cerebrospinal fluid, intracranial pressure can rise causing headaches, nausea, and vomiting.

Less common are benign cysts and cyst-like tumors called cystadenomas.

The most concerning, occurring in ~25% of VHL patients, is the endolymphatic sac tumor of the inner ear which can cause deafness.

Summary

Von-Hippel Lindau (VHL) is a genetic disease that increases the risk of tumor formation in the CNS, kidneys, adrenal glands, and pancreas. It is caused by a mutated tumor suppressor gene, VHL, which increases the risk of tumor formation by upregulating genes that promote cell growth. VHL is inherited in an autosomal dominant pattern and can lead to various benign and malignant tumors. Hemangioblastoma is the most common tumor type, occurring in about 60% of VHL patients, followed by clear cell renal cell carcinoma, pancreatic neuroendocrine tumors, and pheochromocytomas. Regular surveillance is crucial for improving quality of life and lifespan. Treatment recommendations depend on the tumor type and aim to preserve the function of the affected organ.

Elsevier

Copyright © 2023 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.

RELX